VeriMomsalix alba extract은 임신 중 안전한가요?
No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
임신 중 salix alba extract 대체 안전 성분 | VeriMom
Related ingredients
Frequently asked questions
- salix alba extract은 임신 중 안전한가요?
- No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
- salix alba extract은 모유 수유 중 안전한가요?
- LactMed and other clinical sources advise avoidance of willow bark/extract during breastfeeding because salicylates can be transferred and aspirin-like compounds have documented neonatal risks; no harmonised CLP or EU ban was found for the extract itself, but clinical precaution is recommended. Topical cosmetic use would give low but measurable exposure depending on formulation and concentration. (LactMed; WebMD; ECHA registration).
- salix alba extract은 아기 피부에 안전한가요?
- No specific infant dermal reproductive toxicity data were identified and no harmonised CLP or EU ban applies. Because the extract contains salicylates (which can be systemically active) there is a class-based concern (h=1) and a demonstrated metabolic pathway to salicylic acid (m=2). Dermal exposure in infants is higher relative to adults (immature barrier and higher surface-area-to-weight), so exposure score is increased by +1 for 0–3 yr skin compared with adults. Cosmetic topical use at typical low concentrations likely yields low systemic absorption but infant exposure is higher than adult. (PubMed toxicology summaries; LactMed; ECHA registration).
- VeriMom은 salix alba extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 salix alba extract을 60/100 (중간 위험)로 평가합니다.
- 임신 중 salix alba extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.